Our markets
With the overall aim of increasing patient engagement to life-changing treatment and medication, our focus is on long-term conditions, cancer, and rare diseases.
Our mission is to give patients control of their health through knowledge, choice, convenience and connection
Rare diseases & orphan drugs
We’re a global network dedicated to getting rare and orphan medicines to hard-to-reach patients worldwide.
Intelligent Insights
Our Intelligent Insights are enabling healthcare professionals, pharmaceutical companies and biotechs to improve patient health outcomes.
Long-term conditions
As a leading pharma services business, we help those with long-term conditions get the best from their medicines.
Cancer treatments
Delivering a range of treatments, we are the UK’s leading provider of cancer in-home care.
Delivering vital medicines
Cancer care at home
Increasing global access
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.
Thought Leadership
Leveraging Early Access Programs and Real-World Data for commercial success
News
Promising breakthrough for patients with rare form of cancer
A recent breakthrough in the treatment of malignant pleural mesothelioma (MPM) , published in JAMA oncology, may be a pivotal moment…
Blogs/Articles
Mitigating Risks in Early Access Programs: A Guide for Biotech Companies
Early Access Programs (EAPs) can offer a vital lifeline to patients suffering from life-threatening, long-lasting, or seriously debilitating illnesses, providing…